Clinical Trial Update: A Phase 3 STudy of CaPRe in LOwering Very hiGh TriglYcerides (TRILOGY 2) [Phase 3]

View source ↗

Summary

Phase 3 trial update for CaPRe in lowering very high triglycerides (TRILOGY 2) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Drugs mentioned

• Capre

Snippet

Sponsor: Grace Therapeutics Inc. | Conditions: Hypertriglyceridemia | Phase 3 | Status: COMPLETED